Regberg Jakob, Eriksson Jonas N K, Langel Ulo
Department of Neurochemistry, Stockholm University, Svante Arrhenius väg 21A, SE-10691 Stockholm, Sweden.
Front Biosci (Elite Ed). 2013 Jan 1;5(2):509-16. doi: 10.2741/e632.
The field of gene therapy is starting to move towards clinical applications but is currently limited by the lack of efficient delivery systems. Cell-penetrating peptides provide a means of cellular delivery for gene therapy applications as well as delivery of traditional drugs. Using cell-penetrating peptides a range of different cargoes have been successfully delivered into a number of cell types, in vitro as well as in vivo. In this review we discuss uptake mechanisms of different cell-penetrating peptides, with or without cargo. The transition from in vitro to in vivo applications and strategies to increase the bioavailability of cell-penetrating peptides are also discussed.
基因治疗领域正开始朝着临床应用迈进,但目前受到缺乏高效递送系统的限制。细胞穿透肽为基因治疗应用以及传统药物的递送提供了一种细胞递送方式。利用细胞穿透肽,一系列不同的货物已成功在体外和体内递送至多种细胞类型中。在本综述中,我们讨论了不同细胞穿透肽(无论有无货物)的摄取机制。还讨论了从体外应用到体内应用的转变以及提高细胞穿透肽生物利用度的策略。